Utilizing radioconjugate of IGF-1R siRNA, p-SCN-Bn-DTPA, and 177Lu as radiopharmaceutical to suppress CRC cell proliferation caused by upregulation of IGF-1R via triggering apoptosis. Here, IGF1R is linked to colorectal carcinoma.